Skip to main content

Title

Treatment Strategies for Refractory Depression [Number 25] 

Sub Title

 

APPI Author

 

Publication Year

 

APPI ISBN

978-0-88048-184-7 

Item Number

8184 

Price

 

Image

Treatment Strategies for Refractory Depression [Nu 

Description

 

Contents

 

Reviews

 

Contributors

 

Paperback

 

Hardcover

 

Online

 

Media

 

Features

 

Topic

 

GROUP ID

 

ID TITLE

2813 

APPI Status

OP 

Searchable

APPIWEB

 

BIND

Hardcover 

Processed

About the Author

 

ALTID

3,695 

ALTISBN

978-1-58562-446-1 

APPIID

1,029 

APPIPAGES

238 

AUTHOR10ID

 

AUTHOR1ID

5,492 

AUTHOR2ID

 

AUTHOR3ID

 

AUTHOR4ID

 

AUTHOR5ID

 

AUTHOR6ID

 

AUTHOR7ID

 

AUTHOR8ID

 

AUTHOR9ID

 

AUTHORBLURB

Steven P. Roose, M.D., is Associate Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Research Psychiatrist, New York State Psychiatric Institute.

Alexander H. Glassman, M.D., is Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Chief of Clinical Psychopharmacology, New York State Psychiatric Institute.

AUTHORBLURB11

Steven P. Roose, M.D., is Associate Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Research Psychiatrist, New York State Psychiatric Institute.

Alexander H. Glassman, M.D., is Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Chief of Clinical Psychopharmacology, New York State Psychiatric Institute.

AUTHORBLURB12

 

AUTHORBLURB21

 

AUTHORBLURB22

 

BANNER

 

BESTSELLERFORWEB

 

BYLINE1

<a href='/SearchCenter/Pages/default.aspx?k= +APPIAuthor:"&#39;Steven Roose&#39;"' alt='Steven Roose, M.D.' >Steven Roose, M.D.</a>

BYLINE2

 

CONTRIBUTORS1

 

CONTRIBUTORS2

 

COPYRIGHTYEAR

1,990 

DOMPRICEFORMATTED

14.95 

Editable Area 01

Editable Area 02

Editable Area 03

Editable Area 04

Editable Area 05

EDITION

 

FEATUREDHOMEPAGE

 

HIGHLIGHTS1

 

ISBNshort

 

MARKETINGCATEGORYCALC

Mood Disorders 

OMIT_ORDERLINE_INFO

 

ORDERLINE_LINKS

 

POL_BOOK_BLURB

 

PROMOCOPY

Over the years there have been many published articles and symposia on the diagnosis and treatment of refractory depression, but there have been surprisingly few data. This paucity of data reflects the absence of an effective, sustained research effort on this topic.

The authors of Treatment Strategies for Refractory Depression review all available controlled studies as well as the results of open clinical trials to help the clinician answer questions often faced in the clinical setting. Does the treatment fit the illness? Are the patients truly refractory to treatment or simply inadequately treated, and if indeed they appear to be treatment-resistant, resistant to what treatment? Is the methodology appropriately rigorous in studies assessing the effectiveness of alternative treatments in �treatment resistant� depressions? Do factors such as chronicity or personality characteristics predict poor response? Among the many subjects addressed in this volume are lithium augmentation, the use of monoamine oxidase inhibitors, ECT, tricyclic nonresponse, serotonergic agents, thyroid function, chronic depressive disorders, and the effect of Axis II disorders on treatment outcome. Seventeen leading authorities on refractory depression contribute to this volume, the outgrowth of a symposium presented at an annual meeting of the American Psychiatric Association.

PROMOCOPY11

Over the years there have been many published articles and symposia on the diagnosis and treatment of refractory depression, but there have been surprisingly few data. This paucity of data reflects the absence of an effective, sustained research effort on this topic.

The authors of Treatment Strategies for Refractory Depression review all available controlled studies as well as the results of open clinical trials to help the clinician answer questions often faced in the clinical setting. Does the treatment fit the illness? Are the patients truly refractory to treatment or simply inadequately treated, and if indeed they appear to be treatment-resistant, resistant to what treatment? Is the methodology appropriately rigorous in studies assessing the effectiveness of alternative treatments in “treatment resistant” depressions? Do factors such as chronicity or personality characteristics predict poor response? Among the many subjects addressed in this volume are lithium augmentation, the use of monoamine oxidase inhibitors, ECT, tricyclic nonresponse, serotonergic agents, thyroid function, chronic depressive disorders, and the effect of Axis II disorders on treatment outcome. Seventeen leading authorities on refractory depression contribute to this volume, the outgrowth of a symposium presented at an annual meeting of the American Psychiatric Association.

PROMOCOPY12

 

PROMOCOPY21

 

PROMOCOPY22

 

RUNNING_TIME

 

SETITEMNUMBER

 

SUBJECTCODE1MARKCAT

 

SUBJECTCODE2MARKCAT

 

SUBJECTCODE3MARKCAT

 

SUBTITLE1

 

SUBTITLE2

 

SUBTITLE3

 

TOC

Contributors. Introduction to the progress in psychiatry series. Methodological issues in the diagnosis, treatment, and study of refractory depression. Adequate tricyclic treatment: defining the tricyclic nonresponder. Lithium augmentation in refractory depression. The use of monoamine oxidase inhibitors in refractory depression. Carbamazepine and other antiepileptic drugs in refractory depression. Refractory depression and electroconvulsive therapy. Calcium channel blockers in treatment-resistant bipolar and unipolar affective disorders. Serotonergic agents in the treatment of refractory depression. Thyroid function in refractory depression. Chronic depression versus treatment-refractory depression: evaluation and treatment. Axis II personality disorders and personality features in treatment-resistant and refractory depression. Index.

TOC11

Contributors. Introduction to the progress in psychiatry series. Methodological issues in the diagnosis, treatment, and study of refractory depression. Adequate tricyclic treatment: defining the tricyclic nonresponder. Lithium augmentation in refractory depression. The use of monoamine oxidase inhibitors in refractory depression. Carbamazepine and other antiepileptic drugs in refractory depression. Refractory depression and electroconvulsive therapy. Calcium channel blockers in treatment-resistant bipolar and unipolar affective disorders. Serotonergic agents in the treatment of refractory depression. Thyroid function in refractory depression. Chronic depression versus treatment-refractory depression: evaluation and treatment. Axis II personality disorders and personality features in treatment-resistant and refractory depression. Index.

TOC12

 

TOC21

 

TOC22

 

TOPTHREEREVIEWS

 

TOPTHREEREVIEWS11

 

TOPTHREEREVIEWS12

 

TOPTHREEREVIEWS21

 

TOPTHREEREVIEWS22

 

VOLUME

 

VOLUMETITLE

 

ALSOAVAILABLE

 

MAINCATEGORY

Mood Disorders 

REFINEBYMEDIA

Books 

ALSOAVAILABLEFORDETAILS

 

BYLINEWEB1

BYLINEWEB2

 

ORDERLINELINKSWEB

 

MetaDescription

 
Attachments
Content Type: Books
Created at 3/24/2010 12:36 PM  by Daniel Bedassa 
Last modified at 7/22/2014 2:02 AM  by FarmService 
 
Books: Treatment Strategies for Refractory Depression [Number 25]